Androgen and androgen-metabolizing enzymes in metastasized lymph nodes of breast cancer.

[1]  Takashi Suzuki,et al.  Androgen receptor in triple negative breast cancer , 2013, The Journal of Steroid Biochemistry and Molecular Biology.

[2]  Takashi Suzuki,et al.  Immunohistochemical analysis of aromatase in metastatic lymph nodes of breast cancer , 2013, Pathology international.

[3]  P. Argani,et al.  Androgen receptor expression is usually maintained in initial surgically resected breast cancer metastases but is often lost in end-stage metastases found at autopsy. , 2012, Human pathology.

[4]  J. Carroll,et al.  Minireview: The androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene? , 2012, Molecular endocrinology.

[5]  S. Clark,et al.  Androgen receptor expression predicts breast cancer survival: the role of genetic and epigenetic events , 2012, BMC Cancer.

[6]  D Faratian,et al.  Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  T. Traina,et al.  Triple-Negative Breast Cancer: Role of the Androgen Receptor , 2010, Cancer journal.

[8]  Li Jia,et al.  Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer. , 2009, Cancer research.

[9]  M. Bani,et al.  Ki-67 as a prognostic molecular marker in routine clinical use in breast cancer patients. , 2009, Breast.

[10]  A. León,et al.  Androgens and androgen receptors in breast cancer , 2007, Journal of Steroid Biochemistry and Molecular Biology.

[11]  Takashi Suzuki,et al.  5α‐Reductase type 1 and aromatase in breast carcinoma as regulators of in situ androgen production , 2007, International journal of cancer.

[12]  Noriaki Ohuchi,et al.  Sex steroid-producing enzymes in human breast cancer. , 2005, Endocrine-related cancer.

[13]  L. Patrikainen,et al.  Enzymes as modulators in malignant transformation , 2005, The Journal of Steroid Biochemistry and Molecular Biology.

[14]  M. Bryś,et al.  Androgen receptor status in female breast cancer: RT-PCR and Western blot studies , 2002, Journal of Cancer Research and Clinical Oncology.

[15]  Takashi Suzuki,et al.  5alpha-reductases in human breast carcinoma: possible modulator of in situ androgenic actions. , 2001, The Journal of clinical endocrinology and metabolism.

[16]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[17]  D. Allred,et al.  Prognostic and predictive factors in breast cancer by immunohistochemical analysis. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[18]  S J Schnitt,et al.  Interobserver Reproducibility in the Diagnosis of Ductal Proliferative Breast Lesions Using Standardized Criteria , 1992, The American journal of surgical pathology.

[19]  J. Varhaug,et al.  Androgen receptors in operable breast cancer: relation to other steroid hormone receptors, correlations to prognostic factors and predictive value for effect of adjuvant tamoxifen treatment. , 1992, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[20]  B. Park,et al.  Androgen receptor as a targeted therapy for breast cancer. , 2012, American journal of cancer research.

[21]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.

[22]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.